title: Toxoplasmosis in patients with hematologic malignancies.
authors.affiliation: Division of Hematology/Department of Internal Medicine.
authors.forename: Ashish
authors.initials: A
authors.lastname: Chintakuntlawar
authors.forename: Michael
authors.initials: M
authors.lastname: Kidd
authors.forename: Aref
authors.initials: A
authors.lastname: Al-Kali
authors.forename: Walter
authors.initials: W
authors.lastname: Wilson
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D005260:Female; D019337:Hematologic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D014122:Toxoplasma / Q000302:isolation & purification* / Q000502:physiology; D016781:Toxoplasmosis, Cerebral / Q000139:chemically induced / Q000175:diagnosis* / Q000469:parasitology
chemical_list: D000069283:Rituximab; D000069461:Bendamustine Hydrochloride